Spectrum Cannabis provides medical cannabis products to improve the lives of patients around the world. In addition to a consistent supply of lab-tested cannabis medicines, Spectrum Cannabis develops evidence-based education so healthcare professionals can assess cannabis as a form of therapy. As we invest in ongoing research, our goal is to deliver innovative products that raise the bar on therapy and outcomes for patients everywhere.
The Spectrum is a unique colour-coding system designed to make understanding medical cannabis and product selection simple.
Our biopharmaceutical team works to develop a range of effective formulations and delivery mechanisms to serve patients worldwide. We have a number of investigator-initiated and industry collaborations already in place, and are committed to establishing additional relationships.
Researchers at CHI are investigating the potential of medical cannabis in the treatment of fibromyalgia, ALS, anxiety, smoking cessation and more.
We offer a range of products in softgel, ingestible oil, and dried flower formats. Patients and their healthcare providers can use our simple colour-coding system to identify the right products to meet therapeutic needs.